

The U.K.'s Medicines and Healthcare products Regulatory Agency approved Eisai and Biogen's Leqembi for treating mild cognitive impairment and mild dementia due...
You can purchase shares of EISAI CO LTD by Eisai Co., Ltd. (OTCPK:ESALF) through any online brokerage.
There are no as such competitors for EISAI CO LTD by Eisai Co., Ltd..
There is no analysis for EISAI CO LTD by Eisai Co., Ltd. to provide a consensus price target.
The stock price for EISAI CO LTD by Eisai Co., Ltd. (OTCPK: ESALF) is $32.58 last updated November 5, 2026 at 9:30 AM EST.
There are no upcoming dividends for EISAI CO LTD by Eisai Co., Ltd..
EISAI CO LTD by Eisai Co., Ltd. does not have any upcoming earnings scheduled.
There is no upcoming split for EISAI CO LTD by Eisai Co., Ltd..
EISAI CO LTD by Eisai Co., Ltd. is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCPK.
Eisai Co Ltd is a specialty and generic drug manufacturing company. The company's business consists of research and development, manufacturing, sales, import, and export of pharmaceuticals. The pharmaceutical business is categorized by region,...